Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Non-Current Deffered Revenue (2018 - 2025)

Historic Non-Current Deffered Revenue for X4 Pharmaceuticals (XFOR) over the last 2 years, with Q3 2025 value amounting to $789000.0.

  • X4 Pharmaceuticals' Non-Current Deffered Revenue changed N/A to $789000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $789000.0, marking a year-over-year change of. This contributed to the annual value of $417000.0 for FY2018, which is N/A changed from last year.
  • Latest data reveals that X4 Pharmaceuticals reported Non-Current Deffered Revenue of $789000.0 as of Q3 2025.
  • X4 Pharmaceuticals' 5-year Non-Current Deffered Revenue high stood at $955000.0 for Q1 2025, and its period low was $789000.0 during Q3 2025.